Back
Hikma Pharmaceuticals PLC Quote, Financials, Valuation and Earnings
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
43
HKMPF
Hikma Pharmaceuticals PLC
Last Price:
24.87
Seasonality Move:
0.78%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...Hikma Pharmaceuticals PLC Price Quote
$24.87
Hikma Pharmaceuticals PLC Key Stats
Sell
43
Hikma Pharmaceuticals PLC (HKMPF)
is a Sell
Day range:
$24.87 - $24.87
52-week range:
$21.90 - $26.50
Dividend yield:
3.18%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
0
Avg. volume:
49
1-year change:
12.79%
Market cap:
$5.5B
Revenue:
$2.9B
EPS:
$0.85
How Much Does Hikma Pharmaceuticals PLC Make?
-
How Much Are Hikma Pharmaceuticals PLC's Sales Annually?
HKMPF Revenues are $2.9B -
How Much Profit Does Hikma Pharmaceuticals PLC's Make A Year?
HKMPF net income is $190M
Is Hikma Pharmaceuticals PLC Growing As A Company?
Data Unavailable
Hikma Pharmaceuticals PLC Stock Price Performance
-
Did Hikma Pharmaceuticals PLC Stock Go Up Last Month?
Hikma Pharmaceuticals PLC share price went up by 10.24% last month -
Did HKMPF's Share Price Rise Over The Last Year?
HKMPF share price rose by 12.79% over the past 1 year
What Is Hikma Pharmaceuticals PLC 52-Week High & Low?
-
What Is Hikma Pharmaceuticals PLC’s 52-Week High Share Price?
Hikma Pharmaceuticals PLC has traded as high as $26.50 over the past 52 weeks -
What Is Hikma Pharmaceuticals PLC’s 52-Week Low Share Price?
Hikma Pharmaceuticals PLC has traded as low as $21.90 over the past 52 weeks
Hikma Pharmaceuticals PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Hikma Pharmaceuticals PLC?
-
How Much Debt Does Hikma Pharmaceuticals PLC Have?
Total long term debt quarterly is $1.1B -
How Much Cash Does Hikma Pharmaceuticals PLC Have?
Cash and short term investments quarterly total is $229M -
What Is Hikma Pharmaceuticals PLC’s Book Value Per Share?
Book value per share is 9.94
Is Hikma Pharmaceuticals PLC Cash Flow Positive?
-
What Is HKMPF Cash Flow From Operations?
Cash flow from operations (TTM) is $737M -
What Is Hikma Pharmaceuticals PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$337M -
What Is Hikma Pharmaceuticals PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$333M
Hikma Pharmaceuticals PLC Return On Invested Capital
-
Is Management Doing A Good Job?
HKMPF return on invested capital is 5.62% -
What Is Hikma Pharmaceuticals PLC Return On Assets?
ROA measures how assets are converting to revenues and is 4.14% -
What Is HKMPF Return On Equity?
ROE is a measure of profitability and is 8.69%
Hikma Pharmaceuticals PLC Earnings Date & Stock Price
-
What Is Hikma Pharmaceuticals PLC's Stock Price Today?
A single share of HKMPF can be purchased today for 24.87 -
What Is Hikma Pharmaceuticals PLC’s Stock Symbol?
Hikma Pharmaceuticals PLC trades on the otcm under the ticker symbol: HKMPF -
When Is Hikma Pharmaceuticals PLC’s Next Earnings Date?
The next quarterly earnings date for Hikma Pharmaceuticals PLC is scheduled on December 15, 2024 -
When Is HKMPF's next ex-dividend date?
Hikma Pharmaceuticals PLC's next ex-dividend date is August 15, 2024 -
How To Buy Hikma Pharmaceuticals PLC Stock?
You can buy Hikma Pharmaceuticals PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Hikma Pharmaceuticals PLC Competitors
-
Who Are Hikma Pharmaceuticals PLC's Competitors?
Below is a list of companies who compete with Hikma Pharmaceuticals PLC or are related in some way:
Hikma Pharmaceuticals PLC Dividend Yield
-
What Is HKMPF Dividend Yield?
Hikma Pharmaceuticals PLC’s dividend yield currently is 3.18% -
What Is Hikma Pharmaceuticals PLC’s Payout Ratio?
Hikma Pharmaceuticals PLC’s payout ratio is 72.11% -
When Did Hikma Pharmaceuticals PLC Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is Hikma Pharmaceuticals PLC’s Dividend Per Share?
Hikma Pharmaceuticals PLC pays a dividend of $0.00 per share
Hikma Pharmaceuticals PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |